NCT02961595View on ClinicalTrials.gov

Live Enterovirus Vaccine and Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Enterovirus InfectionType 1 DiabetesPrediabetic State
Interventions
BIOLOGICAL

Oral Polio Vaccine (OPV)

Serial Oral Polio Vaccine (OPV) was given to intervention group instead of inactivated poliovirus vaccine (IPV).

All Listed Sponsors
lead

Tampere University

OTHER

NCT02961595 - Live Enterovirus Vaccine and Type 1 Diabetes | Biotech Hunter | Biotech Hunter